DORM vs REGN · P/E 18, rev $2.13B vs P/E 14, rev $14.34B
Dorman Products Inc (DORM) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Dorman Products Inc (DORM) is a auto parts company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported DORM revenue for 2025-12-31 was $2.13B. Net income was $204.2M. Revenue was up 6.0% from 2024-12-31 to 2025-12-31. DORM currently screens at market cap $3.77B and trailing P/E 17.7.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
DORM currently screens at market cap $3.77B and trailing P/E 17.7. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the DORM and REGN stock pages for the full models.
Not investment advice.